CDC73 and breast cancer: In addition, low CDC73 expression is significantly associated with poor relapse free survival of breast cancer patients (p = 0.0017) (Fig. 1C), particularly lymph node-positive breast cancer patients (p = 0.00042) (Fig. 1D).